Nectar Lifescience Financials

NSE: NECLIFE | BSE: 532649

₹11.93

up-down-arrow-0.05 (-0.42%)

As on 10-Sep-2026IST

Market cap

info icon

₹231 Cr

Revenue (TTM)

info icon

₹7 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.4

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
7.44
--
--
1,684.09
1,523.67
1,668.83
Total Income
17.34
10.64
10.41
1,701.14
1,576.73
1,680.15
Total Expenditure
94.20
60.70
0.19
1,532.53
1,470.66
1,510.29
EBITDA
-86.76
-60.70
-0.19
151.55
53.01
158.54
Depreciation
0.46
0.34
0.62
60.72
59.12
56.97
EBIT
-87.22
-61.05
-0.81
90.84
-6.11
101.57
Interest
36.28
37.48
8.53
89.62
89.37
78.81
Other Income
9.90
10.64
10.41
17.06
53.06
11.32
Exceptional Items
88.15
--
--
--
--
--
Profit before Tax
-25.46
-87.88
1.07
18.27
-42.42
34.08
Provision for Tax
-39.82
-30.53
0.38
13.27
-18.24
9.03
Profit after Tax
14.36
-57.35
0.70
5.00
-24.18
25.05
Minority Interest
--
--
--
--
--
--
Share of Associate
--
--
--
--
--
--
Consolidated Profit
-245.06
-292.89
-113.68
5.00
-24.18
25.05

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
582.30
582.30
956.11
1,069.25
1,064.59
1,087.91
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
13.26
-215.28
14.54
141.51
213.12
296.29
Current Liabilities
26.05
26.05
1,021.54
972.82
890.93
1,003.83
Total Liabilities
621.61
621.61
2,047.22
2,191.06
2,189.21
2,390.83

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
329.30
108.31
754.60
899.75
937.46
1,033.18
Current Assets
252.97
252.97
1,237.59
1,283.83
1,231.18
1,354.85
Total Assets
621.61
621.61
2,047.22
2,191.06
2,189.21
2,390.83
Total Debt*
--
--
582.02
635.54
753.83
859.93
Net Current Assets
226.92
226.92
216.05
311.02
340.26
351.02
Contingent Liabilities
--
229.52
101.95
198.18
161.45
75.65

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
-348.72
169.44
224.69
133.65
95.01
Cash Flow from Investing Activities
--
1,208.15
-41.93
-17.03
51.70
16.64
Cash from Financing Activities
--
-766.51
-128.09
-205.44
-185.58
-119.38
Net Cash Inflow / Outflow
--
92.91
-0.58
2.23
-0.23
-7.73

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
-0.72
-15.08
-5.07
0.22
-1.08
1.12
Cash EPS (₹) info
-12.61
-2.93
0.06
2.93
1.56
3.66
Adjusted Book Value (₹) info
29.17
29.98
42.63
47.68
47.47
48.51
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
--
-17.95
7.56
10.02
5.96
4.24
Free Cash Flow per Share (₹) info
--
8.19
9.42
4.69
3.69
-0.33

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
-4.75
0.59
6.12
2.49
5.77
ROE (%) info
-1.21
-7.46
0.07
0.47
-2.25
2.33
ROA (%) info
1.08
-4.80
0.03
0.23
-1.06
1.05
EBIT Margin (%) info
-1,171.85
--
--
5.39
-0.40
6.09
Net Margin (%) info
82.84
-538.87
6.70
0.29
-1.53
1.49
Cash Profit Margin (%) info
0.00
--
--
3.41
2.00
4.26

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
29.44
--
-100.00
10.53
-8.70
8.13
EBIT Growth (%) info
-5,157.44
-7,473.82
-100.89
1,586.17
-106.02
146.53
Net Profit Growth (%) info
-46,139.07
-8,327.69
-86.05
120.66
-196.55
134.19
EPS Growth (%) info
-43.39
-197.43
-2,376.25
120.65
-196.54
134.19
Book Value Growth (%) info
--
-39.10
-10.58
0.44
-2.14
2.44

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
-16.87
--
--
135.18
--
21.53
Price / Book Value info
0.41
0.31
0.54
0.63
0.33
0.50
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
-1.55
-1.37
105.53
7.66
10.30
8.13
Close Price (₹) info
11.57
9.30
22.95
30.15
15.95
24.05
High Price (₹) info
23.87
28.27
56.50
45.70
34.20
48.40
Low Price (₹) info
9.20
9.30
21.85
14.36
14.36
18.55
Market Cap (₹ Cr) info
231.36
--
--
675.32
355.62
539.37

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
--
--
0.61
0.59
0.71
0.79
Short term debt to equity ratio info
--
--
0.46
0.39
0.43
0.46
Current Ratio info
9.71
9.71
1.21
1.32
1.38
1.35
Quick Ratio info
9.70
9.70
0.54
0.59
0.63
0.69
Interest Coverage info
0.30
-1.34
1.13
1.20
0.53
1.43

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
--
--
--
22.52
18.35
26.78
Asset Turnover info
0.01
--
--
0.89
0.77
0.81
Receivable days info
--
--
--
62.43
75.92
77.89
Inventory Days info
--
--
--
130.94
139.23
118.26
Payable days info
--
--
--
112.09
109.47
107.25
Cash Conversion Cycle info
--
--
--
81.28
105.68
88.90
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...